Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Eosinophil mediator release refers to the process by which eosinophils secrete a variety of bioactive molecules, including cytotoxic granule proteins, cytokines, chemokines, lipid mediators, enzymes, and growth factors, into surrounding tissues. This release is central to eosinophil function in immune responses, particularly in allergic inflammation and defense against parasites. The mechanisms of release include degranulation (classical and piecemeal) and constitutive secretion. Excessive or dysregulated release contributes to tissue injury in diseases such as asthma, allergic rhinitis, and certain forms of COPD.
Modulation of eosinophil activation and mediator release
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Eosinophil Mediator Release.